Alteração de nome deferida
#25.4
10/25/2022
RPI 2703
Application data
Number
122021002471Type
Filing
Publication
PCT
US2012027754 The patent was granted on 06/14/2022 and is in force until 03/05/2027. Until then, no one may make, use or sell the invention in Brazil without the owner's authorisation.
Protection valid until:03/05/2027
Latest action published by the INPI: 10/25/2022. We update with every new RPI gazette, published weekly.
Applicants
IMPEL NEUROPHARMA INC.
US
IMPEL PHARMACEUTICALS INC.
US
Inventors
A. B. (pessoa física)
US
J. R. (pessoa física)
US
J. H. (pessoa física)
US
M. H. (pessoa física)
US
R. H. (pessoa física)
US
IPC Classification
Priority claims
US
61/449,008 · 03/03/2011
US
61/451,935 · 03/11/2011
US
61/484,025 · 05/09/2011
US
61/498,974 · 06/20/2011
Publications in the Brazilian Industrial Property Gazette (RPI).
#25.4
10/25/2022
RPI 2703
#16.1
Prazo de Validade: 20 (vinte) anos contados a partir de 05/03/2012, observadas as condições legais. Patente concedida conforme ADI 5.529/DF, que determina a alteração do prazo de concessão.
06/14/2022
RPI 2684
#9.1
05/10/2022
RPI 2679
#7.1
12/14/2021
RPI 2658
#15.35
10/19/2021
RPI 2650
#6.21
05/18/2021
RPI 2628
#2.4
04/06/2021
RPI 2622
#2.5
Dividido do PCT 11 2013 022249-2
03/02/2021
RPI 2617
#2.10
Número de Protocolo '870210013608' em 09/02/2021 16:14 (WB)
02/23/2021
RPI 2616
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.